Description

4-(Morpholinomethyl)Benzoic Acid (4,5-Dihydro-4-Oxo-1H-Pyrazolo[3,4-D]Pyrimidine-1-Yl)Methyl Ester is a high-purity, advanced pharmaceutical intermediate designed for the synthesis of complex active pharmaceutical ingredients (APIs). This compound is critical for research and development in medicinal chemistry, offering a key building block for creating novel therapeutic agents. It is primarily utilized by pharmaceutical manufacturers and R&D laboratories focused on developing innovative drug candidates.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of complex heterocyclic APIs, particularly those targeting kinase inhibition.
• Medicinal Chemistry Research: Used as a sophisticated scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Biochemical Research: Serves as a tool compound for investigating biological pathways and enzyme interactions in vitro.
• Contract Manufacturing (CMO): Supplied to contract development and manufacturing organizations (CDMOs) for cGMP production of clinical trial materials and commercial APIs.
• Academic Research: Utilized in university and institutional labs for advanced synthetic organic chemistry and pharmacology studies.

Basic Information

Product Name	4-(Morpholinomethyl)Benzoic Acid (4,5-Dihydro-4-Oxo-1H-Pyrazolo[3,4-D]Pyrimidine-1-Yl)Methyl Ester
CAS No.	131402-47-6
Molecular Formula	C18H18N4O4
Molecular Weight	354.36 g/mol
Synonyms	4-(Morpholin-4-ylmethyl)benzoic acid (4,5-dihydro-4-oxo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl ester; 1-[[[4-(Morpholinomethyl)benzoyl]oxy]methyl]-4,5-dihydro-4-oxo-1H-pyrazolo[3,4-d]pyrimidine; (4,5-Dihydro-4-oxo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl 4-(morpholinomethyl)benzoate; 4-(Morpholinomethyl)benzoic Acid (4,5-Dihydro-4-oxo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl Ester; 1H-Pyrazolo[3,4-d]pyrimidin-1-ylmethyl 4-(morpholinomethyl)benzoate
EINECS	Contact for details

Quality Control

Our 4-(Morpholinomethyl)Benzoic Acid (4,5-Dihydro-4-Oxo-1H-Pyrazolo[3,4-D]Pyrimidine-1-Yl)Methyl Ester is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the stringent requirements for pharmaceutical intermediates. Certificates of Analysis (COA) detailing all specifications are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after each use to prevent degradation from atmospheric moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.